Local quantitative alterations of fibrillin-3, perlecan, collagen type IV and proteins like pentraxin-3 (PTX3) are correlated with the PCOS phenotype (Ma et al., 2020). The gene discussed is PTX3; the disease is polycystic ovary syndrome.